Momentum leaders · current
US momentum leaders — September 2026
As of 10 September 2026
ASST is up 115.3% over one month, ARX 58.4%, and HTFL 56.0%. Leadership spans Financial Services, Healthcare, and an unclassified company rather than one shared sector. In a neutral regime, 41.3% breadth above the 200-EMA and SPY +6.2% versus its 200-EMA point to selective, mixed-market momentum.
Strive, Inc.'s bitcoin-treasury premium thesis depends on increasing bitcoin per diluted common share. A company-reported year-to-date Bitcoin…
Fixed-price take-private: $20.25 all-cash from Thoma Bravo, with the 2026-09-04 close of $19.88 leaving a $0.37 gross spread on an…
The post-Q2 re-rating is intact but the marginal bid now pays above the whole published target band: the 2026-09-02 close of $50.00 sits above the…
the last close carried into coverage is $13.58 (2026-09-04) against a $13.82 52-week high — and the leg on offer is a fifth straight FY2026 guide…
New-CEO deleveraging story: Fabio Schvartsman replaced 24-year CEO Benjamin Steinbruch on 2026-09-03 and the ADR ran from $1.13 (09-01) to $1.22…
Broken IPO that cleared its 2026-07-21 lockup without a supply flood but is grinding on the $4.665 all-time low with no bounce; Goldman cut its…
Forward Industries' Solana treasury re-rating requires growing tokens per share and a verified recovery to net asset value. Updated disclosure…
CVR Energy’s refining thesis is that Hormuz disruption lifts reported margins above second-quarter 2026’s $9.94 per throughput barrel.…
Immuron’s consumer-health expansion needs a dated US PROIBS launch and disclosed commercial terms to validate its September repricing. The…
Beaten-down vertical-SaaS front-office platform for healthcare SMBs, down ~36% YTD and basing off the $4.24 low, repositioning around…
Alpha Metallurgical Resources’ coal-supply-shock thesis requires stronger third-quarter realized pricing before August support breaks. Realization…
Single-asset cardiology micro-cap re-rating on Phase II publication flow and Canaccord's 2026-08-17 Buy reiteration at a $10 target; the shares…
Alvotech's recovery prices in Q4 2026 FDA approvals after the Reykjavik inspection closure announced on 2026-07-29. AVT05 and AVT06 approvals…
Bullish's regulatory repricing thesis requires successful CLARITY Act cloture followed by a weekly close above $37.10 before a weekly close below…
RCM Technologies’ energy-services re-rating requires continued Engineering growth and stable margins. Q3 revenue above the segment’s $39.5 million…
The post-print re-rate topped at an all-time closing high of $64.43 on 2026-08-24 and faded 7.2% to $59.78 by 2026-08-28, with no broker revision…
Launch-ramp re-rating has stopped extending and started digesting: the 2026-09-02 close of $18.86 sits 2.4% under the $19.32 52-week high with…
SharpLink's Ether treasury discount is the recovery thesis: The Block reported a 0.84-times net asset value multiple on 2026-09-07. The case plays…
Strategy Inc.'s bitcoin accumulation thesis needs successive purchase disclosures and STRC recovering its $100 stated amount. Those milestones…
The binary resolved on 2026-08-18 (LUCIDITY: 55% cut in Level 2/3 hypoglycemic events, p=0.000003) and the launch was funded at $35.50 on…
Premium-to-NAV funding engine is closed; the 2026-08-10 release shows capital flipping from coin to float — 7,391 ETH bought for $14.3M (smallest…
Icovamenib's beta-cell-preservation story got a dated readout when COVALENT-211 completed enrollment on 2026-08-24, but the same release pushed…
Kiavi closed 2026-09-01, eleven weeks ahead of the merger end date, and the tape did not pay for it: the 2026-09-04 close of $35.96 sits below the…
Broken compounder with exactly one dated event: the 2026-09-09 pre-market Q2 print. Price ran $13.22 (2026-08-21) to $14.35 (2026-08-28) on no…
The operating leg has printed and only the undated Ipiranga stake sale is left to underwrite the premium: the 2026-08-28 close of $6.45 sits 2.0%…
Refining-crack plus break-up story now trades above nearly every published mark: the 2026-09-04 close of $105.41 sits 0.7% under the 52-week high…
Circle Internet Group's Arc-led infrastructure breakout failed when its 2026-09-09 close of $92.99 breached the published $95 boundary. The…
The turnaround guide was retracted on 2026-08-06 and no desk has re-rated since DA Davidson's 2026-08-10 cut to $5.50. What has carried the shares…
Non-China tungsten narrative now trades on one venue: the TSX exit took effect 2026-07-31 and the ASX removal 2026-09-01, leaving Nasdaq and…
Titan Machinery’s farm-equipment recovery re-rating requires falling total inventory and preserved earnings guidance at its next quarterly report.…
CNH Industrial's farm-equipment recovery is being priced ahead of earnings after September's analyst upgrades. The next quarterly report tests…
Timeline-compression leg still printing highs on thinning inputs: the 2026-09-02 close of $52.68 is a fresh 52-week high, but RSI(14) fell to 73.2…
"3-mo price move" is the stock's market price change, not a FrontierPicks return.
How this board is built
Every name in the US equity universe is scored on a composite momentum score — 1-month price trend 50%, 3-month trend 20% and acceleration 30% — computed arithmetically from daily closes and ranked highest-first. No model orders the board — the ranking is arithmetic. The "3-mo price move" column is one of the three inputs to that score, weighted 20% — not the ranking itself, so rows do not descend in it. The board reflects price moves already made, not a forecast. Each covered name links to its dated research dossier — thesis, invalidation trigger, archetype and catalyst.
Past months
Each month's board is frozen when the month closes and kept unchanged — the record of what led, when.
Questions
- What are the hottest US stocks right now?
- As of 10 September 2026, the US names with the strongest composite momentum score on FrontierPicks are ASST, ARX, HTFL, AVAH. This is a momentum ranking of price moves already made — research, not advice.
- How is this momentum ranking built?
- Every name in the US equity universe is scored on a composite momentum score — 1-month price trend 50%, 3-month trend 20% and acceleration 30% — computed arithmetically from daily closes, then ranked highest-first. The arithmetic is the whole ranking — no model orders the board. Each covered name links to its dated research dossier. Methodology is open.
- Is a high ranking a recommendation?
- No. The board reflects price moves that have already happened, not a forecast or a recommendation. It is educational research, not investment advice.
As of 10 September 2026 · research, not advice.